Your browser doesn't support javascript.
loading
Meta-analysis of studies using statins as a reducer for primary liver cancer risk.
Zhong, Guo-Chao; Liu, Yan; Ye, Yuan-Yuan; Hao, Fa-Bao; Wang, Kang; Gong, Jian-Ping.
Afiliação
  • Zhong GC; Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
  • Liu Y; Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
  • Ye YY; Department of Gastroenterology, The Fifth People's Hospital of Chengdu, Chengdu 611130, China.
  • Hao FB; Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
  • Wang K; Department of Pediatric Surgery, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
  • Gong JP; Department of Breast and Endocrine Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Sci Rep ; 6: 26256, 2016 05 20.
Article em En | MEDLINE | ID: mdl-27198922

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article